title: Mortality benefits of influenza vaccination in elderly people.
authors.forename: Carel
authors.initials: C
authors.lastname: Thijs
authors.forename: Walter E P
authors.initials: WE
authors.lastname: Beyer
authors.forename: Phile M E
authors.initials: PM
authors.lastname: Govaert
authors.forename: Marc J W
authors.initials: MJ
authors.lastname: Sprenger
authors.forename: Geert-Jan
authors.initials: GJ
authors.lastname: Dinant
authors.forename: André
authors.initials: A
authors.lastname: Knottnerus
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D017589:Immunization Programs; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D053122:Influenza A Virus, H3N2 Subtype / Q000276:immunology; D009980:Influenza A virus / Q000276:immunology; D009981:Influenza B virus / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage; D007251:Influenza, Human / Q000453:epidemiology / Q000401:mortality* / Q000517:prevention & control*; D008875:Middle Aged; D009026:Mortality; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D007252:Influenza Vaccines